Natural Shrimp, Inc., a biotechnology aquaculture company, recently completed a significant 6-month trial in Japan, demonstrating the effectiveness of its patented Electrocoagulation (EC) and Hydrogas technologies in shrimp farming. The trial, conducted at a Japanese shrimp research facility, aimed to evaluate the performance of these technologies within a recirculating aquaculture system (RAS).

Installation and Operational Performance

Upon arrival in Japan, Natural Shrimp’s team, in collaboration with local support, swiftly installed and initiated the operation of the Equipment. The trial involved comparing tanks treated by the EC and Hydrogas with those treated by traditional biofilters. Over the trial period, the EC system effectively removed ammonia from the water, while the presence of Hydrogas correlated with improved shrimp growth rates compared to biofiltration alone.

Natural Shrimp actively engaged in the trial, making three trips to Japan and maintaining remote access to the Equipment between visits. Despite initial instruction by the NSI team, the Japanese team quickly familiarized themselves with the operation of the EC and Hydrogas™ equipment. Extensive testing was conducted under various conditions, including assessments of different flow rates, ammonia levels, and amperage levels, providing valuable empirical data.

Exploring Market Opportunities

Tom Untermeyer, Natural Shrimp’s Chief Technology Officer, emphasized the potential of the Japanese market, citing its reliance on shrimp imports and significant consumption. Untermeyer highlighted the strategic fit of NSI technology in addressing Japan’s needs. Looking forward, Natural Shrimp aims to explore potential joint ventures, licensing agreements, or business collaborations in Japan to further develop shrimp production systems utilizing their technologies.